Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TÖRNIG, J.
Right arrow Articles by AMANN, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TÖRNIG, J.
Right arrow Articles by AMANN, K.
J Am Soc Nephrol 10:77-83, 1999
© 1999 American Society of Nephrology


REGULAR ARTICLES

Hypertrophy of Intramyocardial Arteriolar Smooth Muscle Cells in Experimental Renal Failure

JOHANNES TÖRNIG*, MARIE-LUISE GROSS*, AURELIA SIMONAVICIENE*, GERHARD MALL{ddagger}, EBERHARD RITZ{dagger} and KERSTIN AMANN*

* Department of Pathology, University of Heidelberg, Heidelberg, Germany.
{dagger} Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
{ddagger} Department of Pathology, Städtische Kliniken, Darmstadt, Germany.

Correspondence to Dr. Kerstin Amann, Department of Pathology, Im Neuenheimer Feld 220, D-69120 Heidelberg, Germany. Phone: 06221-562668; Fax: 06221-565251; E-mail: kerstin_amann{at}ukl.uni-heidelberg.de

Abstract. Wall thickening of intramyocardial arteries in patients with chronic renal failure may contribute to the increased susceptibility of the uremic heart to ischemic injury. In this context, the following questions arise: (1) Is intramyocardial wall thickening in experimental renal failure due to hypertrophy, hyperplasia or both? (2) Which stimuli trigger wall thickening? Using novel stereologic techniques (Nucleator, Selector), intramyocardial arteries were examined in sham-operated and subtotally nephrectomized (SNX) Sprague Dawley rats with moderate renal failure of 8 wk duration. Systolic BP during the experiment was not significantly different in both groups. Absolute and relative left ventricular weight, wall thickness (5.69 ± 1.11 µm versus 4.42 ± 0.99 µm), and wall-to-lumen ratio of intramyocardial arteries (0.117 ± 0.03 µm/µm versus 0.089 ± 0.01 µm/µm) were significantly greater in SNX than in sham-operated rats. The mean cell and nuclear volume of intramyocardial arteriolar smooth muscle cells was significantly increased in SNX rats (650 ± 230 µm3 versus 430 ± 90 µm3 and 26 ± 4.5 versus 19.9 ± 2.2 µm3, respectively). In parallel, the total arteriolar wall volume was significantly greater in the left ventricle of SNX (+ 58%) compared with sham rats. In contrast, the total length of all left ventricular arteries was comparable in both groups. The increase in mean cell volume without significant change in cell number indicates that arteriolar wall thickening in the heart of SNX rats is explained by hypertrophy rather than hyperplasia of arterial smooth muscle cells. This finding in a nonhypertensive experimental model of chronic renal failure contrasts with findings in spontaneously hypertensive rats. Independent of BP and left ventricular hypertrophy, specific growth signals must act on cardiac arteriolar smooth muscle cells.




This article has been cited by other articles:


Home page
CJASNHome page
J. Nogueira and M. Weir
The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 766 - 785.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. G. Bongartz, M. J. Cramer, P. A. Doevendans, J. A. Joles, and B. Braam
The severe cardiorenal syndrome: 'Guyton revisited'
Eur. Heart J., January 1, 2005; 26(1): 11 - 17.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. J. W. Bos, M. M. Demircan, J. J. Weening, R. T. Krediet, and A. C. van der Wal
Renal vascular changes in renal disease independent of hypertension
Nephrol. Dial. Transplant., March 1, 2001; 16(3): 537 - 541.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Amann and E. Ritz
Microvascular disease--the Cinderella of uraemic heart disease
Nephrol. Dial. Transplant., October 1, 2000; 15(10): 1493 - 1503.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
U. Schwarz, M. Buzello, E. Ritz, G. Stein, G. Raabe, G. Wiest, G. Mall, and K. Amann
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure
Nephrol. Dial. Transplant., February 1, 2000; 15(2): 218 - 223.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP